AbbVie’s Post

Tune in as Daejin Abidoye joins a #FierceBiotech panel to share his insights on antibody-drug conjugates (#ADCs) and how we’re working to advance novel #cancer treatment options for patients. Learn more about our work in oncology: https://bit.ly/3NtOhbc

Keya Watkins shares her key takeaways from the 2024 Society for Immunotherapy of Cancer (SITC) conference. While there has been a lot of progress in recent years, there is much more work (and many successes) ahead. Read about the presentations she attended and where the convergence of technology and science will help us to develop new oncology treatments. https://hubs.li/Q02Z-M8y0 #SITC2024 #InnovationsTechnology #ScienceAdvancements #OncologyBreakthroughs #ConnectWithCatalyst

It's not too late to register for this week's webinar, Oncology 2050: Have We Been Thinking About the Management of Cancer in the Right Way? Join us as we dive into the future of oncology, redefining treatment strategies, advancing AI, and more. Register at https://lnkd.in/gRc_wcPh Hear from our panel of experts, including Axel Hoos, Peter Sandor, EVP, Astellas Pharma US, and Lumanity's Jeff Bockman, Viraj Parekh, and Dennis Chang. #Oncology #Cancer #CancerProgress #CancerTreatment #AIinCancerTreatment

So exciting! #OPTIMA is now open in Thailand at #QueenSirikitCenter with Dr sarun thongvitokomarn The OPTIMA trial aims to find out if using #Prosigna Breast Cancer Assay can help make safe and accurate decisions about whether or not chemotherapy treatment is needed for patients with ER-positive, HER2-negative #earlybreastcancer.

Tune into the webinar from SPCC below if you are interested in hearing me discuss an amazing drug development story in ALK+ lung cancer: “The story of ALK - crizotinib to lorlatinib”

Want to learn more about the role of RNA in oncology? Tune in to the latest episode of Onc Now to find out, featuring Sarah Blagden CEO of RNA GUARDIAN LTD, who explores the latest breakthroughs in oncology, the future of cancer prevention, and the potential of innovative therapies. Watch here: https://hubs.la/Q02X4h2Y0

For #TrialTuesday, learn about the CompassHER2 RD trial (Alliance A011801) led by Dr. Ciara O'Sullivan, of the Mayo Clinic. This trial aims to see how targeted therapy linked to a chemotherapy drug works to prevent #breastcancer from returning in patients with high-risk HER2+ breast cancer. To find out more, visit https://lnkd.in/g_PjJ9e3 #NCI #NCTN #BCsm

Numerous studies have shown that stress can not only contribute to cancer initiation and impair treatment effectiveness but can also promote cancer growth and the development of metastases[1]. To achieve better overall outcomes in oncology, it is imperative to identify additional sources of stress in cancer patients and address them effectively. To read the article, click here: https://lnkd.in/epZeUqj4

Cervical Cancer: Are You Updated on the Latest in Treatment and Management? Evidence-Based Treatment of Cervical Cancer: An Interactive Case Challenge for Oncology Providers | 0.25-hour CME/CE | #MedEd #cme #cervicalcancertreatment | https://bit.ly/3XsmspM

Cervical Cancer: Are You Updated on the Latest in Treatment and Management? Evidence-Based Treatment of Cervical Cancer: An Interactive Case Challenge for Oncology Providers | 0.25-hour CME/CE | #MedEd #cme #cervicalcancertreatment | https://bit.ly/3XsmspM